CAN

  • THE CENTRE
    • Mission
    • News & Events
    • Careers
    • Our Collaborators
    • Funding & Support
      • Donate
      • Our Partners
    • Staff Directory
      • Administrative Staff
      • Dr. Matthew Farrer
      • Translational Neuroscience
      • Neurogenetics
      • Computing & Genetic Statistics
      • Clinical Staff
  • FOR COLLABORATORS
    • Genetic Consulting
    • Biobanking
    • Custom Genotyping
    • Sanger & NGS
    • Bioinformatic & Statistical Analysis
    • Plasmid Requests
  • THE SCIENCE
    • Pillars
    • Core Competencies
    • Diseases
      • Dementias
      • Epilepsy
      • Motor Neurone Disorders
      • Multiple Sclerosis
      • Parkinsonism
    • Research Projects
    • Our Collaborators
    • Publications
    • Staff Bios
  • FOR PATIENTS
    • Patient Participation
    • Clinical Research
    • Patient Resources
    • Clinical Staff
You are here: Home / Centre for Applied Neurogenetics / Funding & Support / Our Partners

Our Partners

shutterstock_180419078The Centre for Applied Neurogenetics  (CAN) is able to pursue its cutting-edge research through the generous support of private and public agencies. Funding for our research comes from a variety of sources.: from federal funding (Canadian Excellence Research Chairs program, Canadian Foundation for Innovation) to disease-specific charities and partnerships with the pharmaceutical industry. Investment from the latter is directed primarily towards translational research.

Current support

cercCanada Excellence Research Chair Program
website

  • Funding to help establish the Centre for Applied Neurogenetics

LEEF-logoLeading Edge Endowment Fund
website

  • Endowment fund to support the BC Leadership Chair in Genetic Medicine

cihr-logoCanadian Institutes of Health Research
website

  • Operating grant: Molecular neuroscience of Parkinson’s Disease: Retromer (VPS35) dysfunction
  • Operating grant: Implicating novel genes in familial Parkinsonism

The Peter Cundill Foundation

  • Understanding Parkinsonism, FXTAS and related neurodegenerative diseases using  molecular neuroscience
  • Advancing the cure for Parkinson’s Disease

Michael J. Fox Foundation
website

  • Cognitive Biomarkers: Parkinson’s disease, alpha-synuclein and cognitive medicine.
  • The role of LRRK2 in dopamine modulation of striatal glutamate transmission.
  • Longitudinal characterization of G2019S KI mice: Physiological and behavioral analyses of dopamine and gluatamate systems.
  • Parkinson’s Progression Markers Initiative: Clinical, imaging and plasma and CSF correlates of alpha-synuclein genomic variability
LATEST BRAINWAVES: News & Events
IT'S A NO BRAINER:
Your donations fuel our research. Contact us for more information.
feat-img-footer-CBH-760
  • site map
  • terms of use
  • glossary
  • contact

© 2021, Centre for Applied Neurogenetics · site by Mucky Dog Web Projects · Admin